| scholarly article | Q13442814 |
| P50 | author | Timothy P Padera | Q37382042 |
| P2093 | author name string | Ethel R Pereira | |
| Dennis Jones | |||
| P2860 | cites work | The clinical significance of tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinoma | Q21245478 |
| Involvement of chemokine receptors in breast cancer metastasis | Q24290909 | ||
| Drug concentrations in axillary lymph nodes after lymphatic chemotherapy on patients with breast cancer | Q24806446 | ||
| B cell regulation of the anti-tumor response and role in carcinogenesis | Q26738867 | ||
| Regulation of immune responses by extracellular vesicles | Q27006748 | ||
| Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses. | Q27310763 | ||
| Visualization of immediate immune responses to pioneer metastatic cells in the lung. | Q27314749 | ||
| Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy | Q27690653 | ||
| High Endothelial Venules and Lymphatic Vessels in Tertiary Lymphoid Organs: Characteristics, Functions, and Regulation | Q28069933 | ||
| VEGF-D promotes the metastatic spread of tumor cells via the lymphatics | Q28200072 | ||
| In search of the 'missing self': MHC molecules and NK cell recognition | Q28250846 | ||
| Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial | Q28305038 | ||
| Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion. | Q38901907 | ||
| Elements of cancer immunity and the cancer-immune set point | Q39094764 | ||
| B cell regulation in cancer and anti-tumor immunity. | Q39381508 | ||
| Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. | Q39722616 | ||
| Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype | Q39899648 | ||
| Inflamed lymphatic endothelium suppresses dendritic cell maturation and function via Mac-1/ICAM-1-dependent mechanism | Q39984665 | ||
| Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells | Q40068378 | ||
| Preparing the "soil": the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells | Q40216298 | ||
| Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications | Q40243316 | ||
| Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma | Q40577663 | ||
| Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. | Q40727529 | ||
| Lymphovascular invasion of tumor cells in lymph node metastases has a negative impact on survival in esophageal cancer | Q40796495 | ||
| Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity | Q40944056 | ||
| Conduits mediate transport of low-molecular-weight antigen to lymph node follicles | Q41291427 | ||
| Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation. | Q41369903 | ||
| T-cell trafficking facilitated by high endothelial venules is required for tumor control after regulatory T-cell depletion | Q41400520 | ||
| Transmural flow modulates cell and fluid transport functions of lymphatic endothelium | Q42466882 | ||
| VEGF-D deficiency in mice does not affect embryonic or postnatal lymphangiogenesis but reduces lymphatic metastasis. | Q43420394 | ||
| CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma. | Q43899944 | ||
| Depressed natural killer cell activity in cervical lymph nodes containing focal metastatic squamous cell carcinoma | Q45250241 | ||
| Mature cytotoxic CD56(bright)/CD16(+) natural killer cells can infiltrate lymph nodes adjacent to metastatic melanoma | Q45807165 | ||
| Micrometastasis to in-transit lymph nodes from extremity and truncal malignant melanoma | Q46445275 | ||
| Treg Depletion Licenses T Cell-Driven HEV Neogenesis and Promotes Tumor Destruction | Q46646887 | ||
| Lymphatic endothelial S1P promotes mitochondrial function and survival in naive T cells. | Q47105655 | ||
| Emerging Roles for VEGF-D in Human Disease | Q47233157 | ||
| Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma. | Q47678837 | ||
| Towards the prediction of flow-induced shear stress distributions experienced by breast cancer cells in the lymphatics. | Q47884123 | ||
| Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges. | Q47940254 | ||
| Lymph node effective vascular permeability and chemotherapy uptake. | Q48135857 | ||
| High endothelial venule blood vessels for tumor-infiltrating lymphocytes are associated with lymphotoxin β-producing dendritic cells in human breast cancer. | Q50859541 | ||
| Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas. | Q51191431 | ||
| Angiogenesis in ductal breast carcinoma. Comparison of microvessel density between primary tumour and lymph node metastasis. | Q52913182 | ||
| Tumor-derived TGFbeta-1 induces dendritic cell apoptosis in the sentinel lymph node. | Q53626971 | ||
| Involvement of an autocrine stromal cell derived factor-1/CXCR4 system on the distant metastasis of human oral squamous cell carcinoma. | Q54563266 | ||
| CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. | Q55053710 | ||
| Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth | Q56825474 | ||
| Photodynamic Ablation of Lymphatic Vessels and Intralymphatic Cancer Cells Prevents Metastasis | Q57381940 | ||
| Association of Angiogenesis in Lymph Node Metastases With Outcome of Breast Cancer | Q57578640 | ||
| Angiogenesis is redundant for tumour growth in lymph node metastases | Q63634044 | ||
| Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells | Q67946431 | ||
| Evidence for novel non-angiogenic pathway in breast-cancer metastasis. Breast Cancer Progression Working Party | Q73837102 | ||
| Lymphatic metastasis in the absence of functional intratumor lymphatics | Q78009338 | ||
| Extralymphatic tumors prepare draining lymph nodes to invasion via a T-cell cross-tolerance process | Q80352316 | ||
| Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node | Q81310337 | ||
| Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis | Q83817384 | ||
| B cell-derived vascular endothelial growth factor A promotes lymphangiogenesis and high endothelial venule expansion in lymph nodes | Q83822188 | ||
| VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics | Q84621185 | ||
| The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis | Q84896778 | ||
| Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling | Q28305764 | ||
| A perspective on cancer cell metastasis | Q28307891 | ||
| The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice | Q28588851 | ||
| Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET | Q29618139 | ||
| Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN | Q29619346 | ||
| Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity | Q30299955 | ||
| Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells | Q30415907 | ||
| Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation | Q30434547 | ||
| Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse | Q30499924 | ||
| Use of a PEG-conjugated bright near-infrared dye for functional imaging of rerouting of tumor lymphatic drainage after sentinel lymph node metastasis | Q30539614 | ||
| Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses. | Q30541916 | ||
| Intravital and whole-organ imaging reveals capture of melanoma-derived antigen by lymph node subcapsular macrophages leading to widespread deposition on follicular dendritic cells | Q30627418 | ||
| Human Melanoma-Derived Extracellular Vesicles Regulate Dendritic Cell Maturation | Q30843339 | ||
| Hypoxia-specific ultrasensitive detection of tumours and cancer cells in vivo | Q30882619 | ||
| Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning | Q33615222 | ||
| Steady-state antigen scavenging, cross-presentation, and CD8+ T cell priming: a new role for lymphatic endothelial cells | Q33630143 | ||
| Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing | Q33693912 | ||
| Senescent tumor cells lead the collective invasion in thyroid cancer | Q33702243 | ||
| Final trial report of sentinel-node biopsy versus nodal observation in melanoma | Q33760173 | ||
| In vivo photolabeling of tumor-infiltrating cells reveals highly regulated egress of T-cell subsets from tumors. | Q33782533 | ||
| Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions | Q33794995 | ||
| Disrupted lymph node and splenic stroma in mice with induced inflammatory melanomas is associated with impaired recruitment of T and dendritic cells. | Q33980128 | ||
| Dendritic-cell trafficking to lymph nodes through lymphatic vessels | Q33989067 | ||
| B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization | Q33993521 | ||
| Fibroblastic reticular cells from lymph nodes attenuate T cell expansion by producing nitric oxide | Q34081643 | ||
| VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium | Q34254937 | ||
| Radiation field design in the ACOSOG Z0011 (Alliance) Trial | Q34451764 | ||
| Regulatory B cells: origin, phenotype, and function. | Q34473148 | ||
| Recognition of tumors by the innate immune system and natural killer cells | Q34496462 | ||
| Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma | Q34499441 | ||
| SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions | Q34518758 | ||
| Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial | Q34919537 | ||
| An overview of lymphatic vessels and their emerging role in cardiovascular disease | Q35366220 | ||
| Lymphatic system: an active pathway for immune protection | Q35417609 | ||
| Lymphangiogenesis: Molecular mechanisms and future promise | Q37697245 | ||
| Interaction of tumor cells and lymphatic vessels in cancer progression | Q37969667 | ||
| Lymphangiogenic factors, mechanisms, and applications | Q38192927 | ||
| Tumor-associated macrophages: from mechanisms to therapy | Q38230880 | ||
| Sentinel lymph node metastases in cancer: causes, detection and their role in disease progression | Q38274767 | ||
| Natural killer cells as helper cells in dendritic cell cancer vaccines | Q38352462 | ||
| Origins of lymphatic and distant metastases in human colorectal cancer. | Q38373329 | ||
| Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer | Q38388371 | ||
| From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity. | Q38608263 | ||
| Tumor lymphangiogenesis and new drug development | Q38679888 | ||
| Targeting regulatory T cells in tumors | Q38703565 | ||
| Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine. | Q38704616 | ||
| RORγt+ Innate Lymphoid Cells Promote Lymph Node Metastasis of Breast Cancers | Q38721561 | ||
| Genome-wide in vivo screen identifies novel host regulators of metastatic colonization | Q38723015 | ||
| Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. | Q38738044 | ||
| Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia | Q38797959 | ||
| Significance of lymph node metastasis in cancer dissemination of head and neck cancer | Q35555487 | ||
| Impaired lymphatic contraction associated with immunosuppression | Q35558779 | ||
| Metastatic breast cancer cells in lymph nodes increase nodal collagen density | Q35580080 | ||
| VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites | Q35616124 | ||
| Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis | Q35750191 | ||
| IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis | Q35763387 | ||
| Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer | Q35987354 | ||
| Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks | Q36007057 | ||
| Lymph node biophysical remodeling is associated with melanoma lymphatic drainage | Q36171323 | ||
| Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool in lymph nodes | Q36278300 | ||
| Investigation of the Lack of Angiogenesis in the Formation of Lymph Node Metastases | Q36294948 | ||
| High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes | Q36373347 | ||
| VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes | Q36384880 | ||
| Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis. | Q36386459 | ||
| Modeling Lymph Flow and Fluid Exchange with Blood Vessels in Lymph Nodes. | Q36388533 | ||
| VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis | Q36403416 | ||
| Lymphoid organ development: from ontogeny to neogenesis | Q36426808 | ||
| Neutrophils support lung colonization of metastasis-initiating breast cancer cells | Q36428411 | ||
| The tumor-draining lymph node as an immune-privileged site | Q36593753 | ||
| Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer | Q36614929 | ||
| G-CSF regulates macrophage phenotype and associates with poor overall survival in human triple-negative breast cancer | Q36821159 | ||
| Local therapy and survival in breast cancer | Q36842320 | ||
| Direct visualization of changes of lymphatic function and drainage pathways in lymph node metastasis of B16F10 melanoma using near-infrared fluorescence imaging | Q36911007 | ||
| Heparanase induces VEGF C and facilitates tumor lymphangiogenesis | Q36953862 | ||
| Immune surveillance against a solid tumor fails because of immunological ignorance | Q37178041 | ||
| Tumor-induced stromal reprogramming drives lymph node transformation | Q37197484 | ||
| Lymphatic vessels regulate immune microenvironments in human and murine melanoma | Q37217526 | ||
| Macrophage-Induced Lymphangiogenesis and Metastasis following Paclitaxel Chemotherapy Is Regulated by VEGFR3 | Q37397162 | ||
| Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases | Q37407384 | ||
| Nodal lymphangiogenesis and metastasis: Role of tumor-induced lymphatic vessel activation in extramammary Paget's disease | Q37413735 | ||
| Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial | Q37604182 | ||
| Tumor-Associated Lymphatic Vessels Upregulate PDL1 to Inhibit T-Cell Activation | Q37622038 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | lymph node | Q170758 |
| evasion of host immune response | Q1660157 | ||
| P304 | page(s) | 36 | |
| P577 | publication date | 2018-02-21 | |
| P1433 | published in | Frontiers in Oncology | Q26839986 |
| P1476 | title | Growth and Immune Evasion of Lymph Node Metastasis. | |
| P478 | volume | 8 |
| Q91935809 | Expression profile analysis identifies IER3 to predict overall survival and promote lymph node metastasis in tongue cancer |
| Q91526523 | Fluids and their mechanics in tumour transit: shaping metastasis |
| Q59329853 | Molecular patterns of cancer colonisation in lymph nodes of breast cancer patients |
| Q99714025 | Nodal characteristics associated with adverse prognosis in oral cavity cancer are linked to host immune status |
| Q64244049 | Support of Tumor Endothelial Cells by Chemokine Receptors |
| Q90677019 | Systemic Correlates of the Tumor Microenvironment |
| Q64274340 | Targeting Lymph Node Sinus Macrophages to Inhibit Lymph Node Metastasis |
| Q96815990 | Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients |
| Q64548670 | Two-way communication between ex vivo tissues on a microfluidic chip: application to tumor-lymph node interaction. |
| Q92835077 | Unlocking the therapeutic potential of primary tumor-draining lymph nodes |
Search more.